Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 17/20 | 0.52 |
| ▸ | EGFR | P00533 | 18/20 | 0.51 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.47 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2542094 | 0.93 | ERBB2 (0.53) | ERBB2EGFRERBB3ERBB4 | |
| SCHEMBL2542639 | 0.90 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL1406731 | 0.82 | ERBB2 (0.74) | ERBB2EGFRERBB3ERBB4 | |
| SCHEMBL2538192 | 0.80 | ERBB2 (0.42) | ERBB2EGFR | |
| SCHEMBL2544081 | 0.80 | ERBB2 (0.49) | ERBB2EGFRERBB3ERBB4 | |
| SCHEMBL2544657 | 0.79 | ERBB2 (0.62) | ERBB2EGFRERBB3ERBB4 | |
| SCHEMBL2546738 | 0.79 | EGFR (0.49) | ERBB2EGFRERBB4 | |
| SCHEMBL2520617 | 0.79 | ERBB2 (0.48) | ERBB2EGFR | |
| SCHEMBL2520931 | 0.78 | EGFR (0.48) | ERBB2EGFRERBB4 | |
| SCHEMBL2539476 | 0.78 | ERBB2 (0.60) | ERBB2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1838712-B8 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2011-10-12 | — | — | EP | claimed |
| EP-1838712-A1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | AstraZeneca AB (SE) | 2007-10-03 | — | — | EP | claimed |
| WO-2006064196-A1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | claimed |
| EP-1838712-B8 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2011-10-12 | — | — | EP | disclosed |
| EP-1838712-A1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | AstraZeneca AB (SE) | 2007-10-03 | — | — | EP | disclosed |
| WO-2006064196-A1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |